|
Dr. Walker is a co-founder of Octagon Research Solutions, Inc. Dr. Walker is a serial entrepreneur and Board-certified dermatologist with almost 15 years of biopharmaceutical and life science industry experience. He began his career in 1992 in Quality Assurance at Johnson and Johnson. He then became a clinical/medical consultant for various biopharmaceutical companies such as Johnson and Johnson, AstraMerck, AstraZeneca, and Genta, Incorporated. While at AstraMerck, Dr. Walker had the honor of serving on the FDA Advisory Committee safety team for the Prescription to OTC switch of Prilosec®.
In 2004, Dr. Walker served as Chief medical officer and principal of Trigenesis Therapeutics, Inc, a Dermatology specialty (development stage) pharmaceutical company. Within 6 months of commencing operations, the company was sold to Dr. Reddy’s Laboratories. Dr. Walker then founded Cutix, Inc., a company focused on the acquisition of dermatology therapeutics. In 2005, Cutix acquired the PreSun® sunscreen brand, a well known in-market (since 1973) sunscreen franchise from Bristol-Myers Squibb.
Additionally, Dr. Walker has several years of business development experience working with large biopharmaceutical companies, start-ups, and universities in the identification, acquisition/licensing, and financing of novel development stage assets and in-market brands. He has worked with various technology transfer/venture arms at University of Pennsylvania, Vanderbilt University, University of Maryland, and Johns Hopkins in the formation of start-up companies around novel biopharmaceutical technologies. Most recently, he co-founded Omentec, Inc., a company formed around a novel target for the treatment of diabetes and obesity discovered at the University of Maryland.
Dr. Walker currently serves on the Advisory Boards of Specialty Diets, Inc., Patient Care Management Associates, Inc., and Flexible Medical Systems, Inc. | 